Prosonix Adds New Investor, Raises $9M for Inhaled Drugs
By Nuala Moran
Wednesday, May 23, 2012
LONDON Particle engineering specialist Prosonix Ltd. has raised a further £5.7 million (US$9 million) in a second closing of Series B funding, taking the total for the round to £17.1 million.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.